ROCKVILLE, MD — April 13 2021 — Psomagen, Inc., a US-based genetic sequencing and data analysis service provider, is collaborating with Swift Biosciences (now part of Integrated DNA Technologies), a pioneer in the development of research-use-only library preparation kits, to offer comprehensive SARS-CoV-2 variant determination using next-generation sequencing (NGS). Early in the pandemic, public health […]
ROCKVILLE, MD — February 23, 2021 — Psomagen, Inc., a US-based genetic sequencing and data analysis service provider, is proud to expand its next-generation sequencing capabilities to include end-to-end single cell sequencing (SCS) services. These services, which include gene expression and single cell immune profiling, are powered by the Chromium platform and Next GEM-based technology […]
Psomagen, Inc. (previously Macrogen Corp.), established in 2004, offers “total genomic solutions” for both clinical and research purposes, mainly focusing on end-to-end sequencing services. The company will expand its services to include personal DNA tests.